Results 71 to 80 of about 48,373 (242)

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease

Hepatology Research, EarlyView.
ABSTRACT Aim Steatotic liver disease (SLD) encompasses a heterogeneous spectrum with varying risks of hepatocellular carcinoma (HCC). Limited sample sizes limit the development of predictive models, particularly for rare outcomes. This study evaluated whether generative artificial intelligence (AI)‐based synthetic data augmentation can enhance HCC risk
Masaya Sato, Takuma Nakatsuka, Yuki Matsushita, Takuma Kaneko, Keisuke Mabuchi, Tomoharu Yamada, Kazuya Okushin, Tatsuya Minami, Yotaro Kudo, Satoshi Kodera, Kazuhiko Koike, Mitsuhiro Fujishiro, Ryosuke Tateishi   +12 more
wiley   +1 more source

Investigation of intrauterine transmission of Hepatitis B Virus to children from HBsAg-positive pregnant women

Journal of Microbiology and Infectious Diseases, 2011
Objectives: Hepatitis B virus is reported to cause fetal and neonatal hepatitis, with a high rate of vertical transmission. The aim of this study was to determine the rate of vertical transmission during the intrauterine period by determining HBsAg ...
Ozcan Deveci, Erkan Yula, Turkan Toka Ozer, Alicem Tekin, Bulent Korkut, Suleyman Durmaz, Suleyman Durmaz   +6 more
doaj   +1 more source

Erlerde HBSAG pozitifliği

, 2015
investigate the HBsAg positivity in soldiers.Sera were taken from soldiers and HBsAg positivity was investigated by using solid-phase dot EIA method. We found the HBsAg positivity rate to be 6.2 % ( 149 / 2400) Despite the availability of vaccines for more than 15 years, hepatitis B virus (HBV) infection continues to be an important public health ...
Yegane Tosun, Selma, Özbakkaloğlu, Beril, Şahin, Ahmet   +2 more
openaire   +2 more sources

Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Hepatology Research, EarlyView.
We carried out proteomic analysis of serum extracellular vesicles to identify biomarkers predictive of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B receiving nucleos(t)ide analog therapy. Candidate proteins identified through proteomic analysis were subsequently quantified in serum by ELISA.
Emi Sometani, Kazuhiro Murai, Hayato Hikita, Jihyun Sung, Satoshi Muraoka, Hidenori Toyoda, Satoshi Tanaka, Takayuki Miyake, Shinji Kuriki, Kenji Fukumoto, Satoshi Shigeno, Yuta Myojin, Kazuki Maesaka, Kumiko Shirai, Yuki Makino, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Jun Adachi, Tomomi Yamada, Tetsuo Takehara   +21 more
wiley   +1 more source

Prevalensi Kejadian Infeksi Virus HbsAg pada Bayi Baru Lahir dari Ibu dengan HbsAg Positif

Obgynia, 2019
Obective: This study aims to determine the incidence of transmission of HBsAg virus infection in newborns infant from mothers with HbsAg positive. Method: Statistic analysis is a descriptive study.
Rengga Pradipta, Roza Sri Yanti
doaj   +1 more source

On‐Treatment Reassessment of Type IV Collagen 7S and M2BPGi‐Qt Improves Long‐Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B

Hepatology Research, EarlyView.
One‐year reassessment of type IV collagen 7S, supported by quantitative M2BPGi‐Qt assessment, helped refine long‐term hepatocellular carcinoma risk stratification in patients with chronic hepatitis B receiving nucleos(t)ide analogue therapy. On‐treatment 4COL7S emerged as a novel marker of residual fibrosis‐related HCC risk.
Kazumi Yamasaki, Hideko Kozuru, Tomoko Sato, Tomoyuki Suehiro, Yasuhide Motoyoshi, Yuki Kugiyama, Akira Saeki, Shinya Nagaoka, Atsumasa Komori, Hiroshi Yatsuhashi   +9 more
wiley   +1 more source

A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus (BBV) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria

HIV Medicine, EarlyView.
Abstract Background Earlier diagnosis of blood‐borne viruses (BBVs)—HIV, hepatitis B (HBV) and hepatitis C (HCV)—remains a significant public‐health focus. Opt‐out testing in secondary healthcare settings can improve early diagnosis and linkage to care as part of BBV transmission elimination targets.
Becky Metcalfe, Karen J. Maxwell, Kirsten Trayner, Max Wilkinson, Sharon Hutchinson, Claudia Estcourt, Alison J. Rodger   +6 more
wiley   +1 more source

The prevalence of HBsAg among pregnant women referred to Kerman maternity hospitals in 1997 [PDF]

Journal of Kerman University of Medical Sciences, 1999
Hepatitis B virus(HBV) is potentialy ba serious and lethal oathogen causing a wide range of diseases such as :fulminant hepatitis,cirrhisis,chronic active hepatitis,and hepatocellular carcinoma.moreover 5-10% of infected adults and 70-90% of infected ...
B.SH Ali
doaj  

UltRaSoUnd‐guided evaLuAtion of metabolic health in a cohort of midlife women with HIV: The URSULA study

HIV Medicine, EarlyView.
Abstract Objectives We aimed to determine the prevalence of metabolic disorders, liver steatosis and metabolic dysfunction‐associated steatotic liver disease (MASLD) in a cohort of middle‐aged women with HIV (WoWH) and to explore associations between liver steatosis, visceral fat depots and carotid atherosclerosis.
Mariacristina Poliseno, Davide Capruzzi, Antonio Cianciaruso, Nicola Colavito, Felicia Dalitto, Vincenzo Giliberti, Vittoria Lobalsamo, Giuliana Metrangolo, Marica Noviello, Alessandra Vigna, Maurizio Zarcone, Francesco Di Gennaro, Vincenzo Ostilio Palmieri, Annalisa Saracino   +13 more
wiley   +1 more source

Gaps in the Cascade of Care Contribute to Poor Liver Cancer Outcomes Among People Living With Hepatitis B: A Multicenter Observational Cohort Study

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa, Joan Ericka Flores, Michael Macisaac, Jack Wallace, Joseph Doyle, Marno Ryan, Thai Hong, Brett Knowles, Adrian Fox, Ashu Jhamb, Tom Sutherland, Stuart Roberts, William Kemp, Ammar Majeed, Marie Sinclair, Rohit Sawhney, Stephen Bloom, Amanda Nicoll, Zina Valaydon, Gauri Mishra, Sid Sood, Diana Lewis, A. Thompson, J. Howell   +23 more
wiley   +1 more source